ciprofloxacin has been researched along with Aortic Dissection in 5 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin increases susceptibility to aortic dissection and rupture in a mouse model of moderate, sporadic AAD." | 7.88 | Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice. ( Azares, AR; Coselli, JS; LeMaire, SA; Luo, W; Ren, P; Shen, YH; Wang, Y; Zhang, C; Zhang, L, 2018) |
| "Ciprofloxacin accelerates aortic root enlargement and increases the incidence of aortic dissection and rupture in Marfan mice, partially by suppressing lysyl oxidase expression and further compromising the inherited defect in aortic elastic fibers." | 4.12 | Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice. ( Barrish, JP; Coselli, JS; LeMaire, SA; Luo, W; Shen, YH; Zhang, L; Zhang, NS; Zhang, Q, 2022) |
| "Based on 3721 adverse event reports, all three fluoroquinolones are associated with aortic aneurysm, and levofloxacin is associated with aortic dissection." | 3.91 | Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system. ( Huang, H; Huang, J; Jia, Y; Meng, L; Qiu, F; Sun, S, 2019) |
| "Ciprofloxacin increases susceptibility to aortic dissection and rupture in a mouse model of moderate, sporadic AAD." | 3.88 | Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice. ( Azares, AR; Coselli, JS; LeMaire, SA; Luo, W; Ren, P; Shen, YH; Wang, Y; Zhang, C; Zhang, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| LeMaire, SA | 2 |
| Zhang, L | 2 |
| Zhang, NS | 1 |
| Luo, W | 2 |
| Barrish, JP | 1 |
| Zhang, Q | 1 |
| Coselli, JS | 2 |
| Shen, YH | 2 |
| Ren, P | 1 |
| Azares, AR | 1 |
| Wang, Y | 1 |
| Zhang, C | 1 |
| Upchurch, GR | 1 |
| Goldstein, MR | 1 |
| Mascitelli, L | 1 |
| Meng, L | 1 |
| Huang, J | 1 |
| Jia, Y | 1 |
| Huang, H | 1 |
| Qiu, F | 1 |
| Sun, S | 1 |
5 other studies available for ciprofloxacin and Aortic Dissection
| Article | Year |
|---|---|
Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice.
Topics: Animals; Anti-Bacterial Agents; Aorta; Aortic Aneurysm; Aortic Dissection; Aortic Rupture; Apoptosis | 2022 |
Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice.
Topics: Animals; Anti-Bacterial Agents; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Cells | 2018 |
Evidence Against the Use of Fluoroquinolones in Patients With Aortic Pathology.
Topics: Animals; Anti-Infective Agents; Aorta; Aortic Dissection; Ciprofloxacin; Fluoroquinolones; Humans; M | 2018 |
Fluoroquinolone Use and Concern About the Cerebral Vasculature.
Topics: Animals; Aortic Dissection; Ciprofloxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests | 2019 |
Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aortic Aneurysm, Thoracic; Aortic | 2019 |